Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Idiopathic Intracranial Hypertension
100%
Optic Nerve
53%
Visual Field
51%
Optical Coherence Tomography
44%
Visual Acuity
36%
Duane Syndrome
33%
Arteritic Anterior Ischemic Optic Neuropathy
33%
Adolescence
33%
Long-Term Outcome
33%
Diseases
23%
Intravitreal Administration
20%
Injection
20%
Vision
20%
Onset Age
19%
Prospective Study
19%
Disease Course
18%
Body Mass Index
17%
Brain Ischemia
16%
Retinal Detachment
16%
Neurofibromatosis Type I
16%
Bevacizumab
16%
Ophthalmic Artery
16%
Exotropia
16%
Fibrosis
16%
Ganglioglioma
16%
Muscle Atrophy
16%
Corrected Distance Visual Acuity
16%
Function Test
16%
Laser Refractive Surgery
16%
Medial Rectus Muscle
16%
Hyperandrogenism
16%
Hydroxylapatite
16%
Arterial Embolism
16%
Peroperative Complication
16%
Postoperative Complication
16%
Brain Pseudotumor
16%
Salivary Gland Biopsy
16%
Sjoegren Syndrome
16%
Monoclonal Antibody
16%
Amblyopia
16%
Syphilis
16%
Telemedicine
16%
Big Data
16%
Familial Disease
16%
Sleep Disorder
16%
Retinal Nerve Fiber Layer
13%
Inflammation
13%
Testosterone
13%
Best Corrected Visual Acuity
12%
Adduction
12%
Keyphrases
Idiopathic Intracranial Hypertension
83%
Visual Acuity
39%
Visual Field Defect
35%
Intraocular Pressure
33%
Intravitreal Injection
33%
Optical Coherence Tomography
33%
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
33%
Optic Nerve
27%
Visual Outcome
26%
Medical Center
25%
Optic Neuritis
23%
Neuro-ophthalmologist
21%
Tonometer
20%
Hypertension Patients
20%
Lumbar Puncture Opening Pressure
19%
Papilledema
19%
Body Mass Index
19%
Best-corrected Visual Acuity
19%
Disease Course
18%
Head Position
16%
Automated Visual Fields
16%
Laser Vision Correction
16%
Aseptic Meningitis
16%
Dexmethylphenidate
16%
Clinical Characteristics
16%
Mass-like
16%
Hyperreflective
16%
Radiologically Isolated
16%
Familial Occurrence
16%
Ocular Nerves
16%
Great Imitator
16%
Tono-Pen Tonometer
16%
Consensus Statement
16%
Hyperandrogenism
16%
Rhegmatogenous Retinal Detachment
16%
Ganglion Cells
16%
Intravenous Thrombolysis
16%
Acute Cerebral Infarction
16%
Ocular Adverse Events
16%
Newly Diagnosed
16%
Aflibercept
16%
Treatment Side Effects
16%
Amblyopia
16%
Different Geographical Areas
16%
Neurofibromatosis Type 1 (NF-1)
16%
Soft Contact Lens
16%
Intraocular Pressure Measurement
16%
Attention Deficit Hyperactivity Disorder
16%
Intraocular Pressure Changes
16%
Ab Externo
16%
